共 11 条
[1]
Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator. O′Connor B,Bonnaud G,Haahtela T,et al. Ann Allergy Asthma Immunol . 2001
[2]
Oral montelukast,inhaled beclomethasone, and placebo for chronic asthma.A randomized,controlled trial. Montelukast/Beclomethasone Study Group. Malmstrom K,Rodriguez-Gomez G,Guerra J,et al. Annals of Internal Medicine . 1999
[3]
A long-term study of the antiinflammatory effect of low-dose budesonide plus formoterol versus high-dose budesonide in asthma. Kips JC,O′Connor BJ,Inman MD,et al. American Journal of Respiratory and Critical Care Medicine . 2000
[4]
Potential masking effects of salmeterol on airway inflammation in asthma. Mcivor RA,Pizzichini E,Turner MO,et al. American Journal of Respiratory and Critical Care Medicine . 1998
[5]
Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Stempel DA,Mauskopf J,McLaughlin T,et al. Respiratory Medicine . 2001
[6]
A comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma. Evans DJ,Taylor DA,Zetterstrom O,et al. The New England Journal of Medicine . 1997
[7]
Mometasone furoate administered once daily is as effective as twice-daily administration for treatment of mild-to-moderate persistent asthma. Kemp JP,Berkowitz RB,Miller SD,et al. The Journal of Allergy and Clinical Immunology . 2000
[8]
Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. Agertoft L,Pedersen S. The New England Journal of Medicine . 2000
[9]
Salmeterol/fluticasone propionate combination therapy 50/250 microg twice daily is more effective than budesonide 800 microg twice daily in treating moderate to severe asthma. Jenkins C,Woolcock AJ,Saarelainen P,et al. Respiratory Medicine . 2000
[10]
Six month claims analysis demonstrates that montelukast is associated with a significantly larger increase in asthma care costs than fluticasone propionate. Stempel DA,Stanford RH,McLaughlin T,et al. American Journal of Respiratory and Critical Care Medicine . 2000